Adaptimmune Therapeutics shares owned by Wetzel Investment Advisors
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Wetzel Investment Advisors
from 13F filings
Historical chart of Wetzel Investment Advisors investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Wetzel Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Adaptimmune Therapeutics by Wetzel Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $5.4k | 6.0k | 0.90 |
2023-12-31 | $2.0k | 3.0k | 0.67 |
More positions owned by Wetzel Investment Advisors
View all positions for Wetzel Investment Advisors